These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 26416646

  • 1. CALHM1 and its polymorphism P86L differentially control Ca²⁺homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β.
    Moreno-Ortega AJ, Buendia I, Mouhid L, Egea J, Lucea S, Ruiz-Nuño A, López MG, Cano-Abad MF.
    Aging Cell; 2015 Dec; 14(6):1094-102. PubMed ID: 26416646
    [Abstract] [Full Text] [Related]

  • 2. Mitochondria sense with different kinetics the calcium entering into HeLa cells through calcium channels CALHM1 and mutated P86L-CALHM1.
    Moreno-Ortega AJ, Ruiz-Nuño A, García AG, Cano-Abad MF.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):722-6. PubMed ID: 19944073
    [Abstract] [Full Text] [Related]

  • 3. CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.
    Koppel J, Campagne F, Vingtdeux V, Dreses-Werringloer U, Ewers M, Rujescu D, Hampel H, Gordon ML, Christen E, Chapuis J, Greenwald BS, Davies P, Marambaud P.
    Mol Med; 2011 Jan 01; 17(9-10):974-9. PubMed ID: 21629967
    [Abstract] [Full Text] [Related]

  • 4. Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis.
    Rubio-Moscardo F, Setó-Salvia N, Pera M, Bosch-Morató M, Plata C, Belbin O, Gené G, Dols-Icardo O, Ingelsson M, Helisalmi S, Soininen H, Hiltunen M, Giedraitis V, Lannfelt L, Frank A, Bullido MJ, Combarros O, Sánchez-Juan P, Boada M, Tárraga L, Pastor P, Pérez-Tur J, Baquero M, Molinuevo JL, Sánchez-Valle R, Fuentes-Prior P, Fortea J, Blesa R, Muñoz FJ, Lleó A, Valverde MA, Clarimón J.
    PLoS One; 2013 Jan 01; 8(9):e74203. PubMed ID: 24069280
    [Abstract] [Full Text] [Related]

  • 5. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
    Dreses-Werringloer U, Lambert JC, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E, Mann D, Lendon C, Campion D, Amouyel P, Davies P, Foskett JK, Campagne F, Marambaud P.
    Cell; 2008 Jun 27; 133(7):1149-61. PubMed ID: 18585350
    [Abstract] [Full Text] [Related]

  • 6. CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.
    Dreses-Werringloer U, Vingtdeux V, Zhao H, Chandakkar P, Davies P, Marambaud P.
    J Cell Sci; 2013 Mar 01; 126(Pt 5):1199-206. PubMed ID: 23345406
    [Abstract] [Full Text] [Related]

  • 7. CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid.
    Giedraitis V, Glaser A, Sarajärvi T, Brundin R, Gunnarsson MD, Schjeide BM, Tanzi RE, Helisalmi S, Pirttilä T, Kilander L, Lannfelt L, Soininen H, Bertram L, Ingelsson M, Hiltunen M.
    Neurosci Lett; 2010 Jan 22; 469(2):265-7. PubMed ID: 20005921
    [Abstract] [Full Text] [Related]

  • 8. Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis.
    Mun MJ, Kim JH, Choi JY, Jang WC.
    Neurosci Lett; 2016 Apr 21; 619():8-14. PubMed ID: 26944452
    [Abstract] [Full Text] [Related]

  • 9. Effect of the CALHM1 G330D and R154H human variants on the control of cytosolic Ca2+ and Aβ levels.
    Vingtdeux V, Tanis JE, Chandakkar P, Zhao H, Dreses-Werringloer U, Campagne F, Foskett JK, Marambaud P.
    PLoS One; 2014 Apr 21; 9(11):e112484. PubMed ID: 25386646
    [Abstract] [Full Text] [Related]

  • 10. CALHM1 ion channel elicits amyloid-β clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain.
    Vingtdeux V, Chandakkar P, Zhao H, Blanc L, Ruiz S, Marambaud P.
    J Cell Sci; 2015 Jul 01; 128(13):2330-8. PubMed ID: 25999473
    [Abstract] [Full Text] [Related]

  • 11. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.
    Boada M, Antúnez C, López-Arrieta J, Galán JJ, Morón FJ, Hernández I, Marín J, Martínez-Lage P, Alegret M, Carrasco JM, Moreno C, Real LM, González-Pérez A, Tárraga L, Ruiz A.
    J Alzheimers Dis; 2010 Jul 01; 20(1):247-51. PubMed ID: 20164592
    [Abstract] [Full Text] [Related]

  • 12. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.
    Nacmias B, Tedde A, Bagnoli S, Lucenteforte E, Cellini E, Piaceri I, Guarnieri BM, Bessi V, Bracco L, Sorbi S.
    J Alzheimers Dis; 2010 Jul 01; 20(1):37-41. PubMed ID: 20164602
    [Abstract] [Full Text] [Related]

  • 13. Calcium homeostasis modulator (CALHM) ion channels.
    Ma Z, Tanis JE, Taruno A, Foskett JK.
    Pflugers Arch; 2016 Mar 01; 468(3):395-403. PubMed ID: 26603282
    [Abstract] [Full Text] [Related]

  • 14. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study.
    Lambert JC, Sleegers K, González-Pérez A, Ingelsson M, Beecham GW, Hiltunen M, Combarros O, Bullido MJ, Brouwers N, Bettens K, Berr C, Pasquier F, Richard F, Dekosky ST, Hannequin D, Haines JL, Tognoni G, Fiévet N, Dartigues JF, Tzourio C, Engelborghs S, Arosio B, Coto E, De Deyn P, Del Zompo M, Mateo I, Boada M, Antunez C, Lopez-Arrieta J, Epelbaum J, Schjeide BM, Frank-Garcia A, Giedraitis V, Helisalmi S, Porcellini E, Pilotto A, Forti P, Ferri R, Delepine M, Zelenika D, Lathrop M, Scarpini E, Siciliano G, Solfrizzi V, Sorbi S, Spalletta G, Ravaglia G, Valdivieso F, Vepsäläinen S, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossù P, Hanon O, Piccardi P, Annoni G, Mann D, Marambaud P, Seripa D, Galimberti D, Tanzi RE, Bertram L, Lendon C, Lannfelt L, Licastro F, Campion D, Pericak-Vance MA, Soininen H, Van Broeckhoven C, Alpérovitch A, Ruiz A, Kamboh MI, Amouyel P.
    J Alzheimers Dis; 2010 Mar 01; 22(1):247-55. PubMed ID: 20847397
    [Abstract] [Full Text] [Related]

  • 15. Lack of association between CALHM1 p.P86L variation and Alzheimer's disease in the Han Chinese population.
    Tao QQ, Sun YM, Liu ZJ, Yang P, Li HL, Lu SJ, Wu ZY.
    Neurobiol Aging; 2014 Aug 01; 35(8):1956.e13-4. PubMed ID: 24630757
    [Abstract] [Full Text] [Related]

  • 16. CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the Chinese population.
    Cui PJ, Zheng L, Cao L, Wang Y, Deng YL, Wang G, Xu W, Tang HD, Ma JF, Zhang T, Ding JQ, Cheng Q, Chen SD.
    J Alzheimers Dis; 2010 Aug 01; 19(1):31-5. PubMed ID: 20061624
    [Abstract] [Full Text] [Related]

  • 17. CALHM1 polymorphism is not associated with late-onset Alzheimer disease.
    Beecham GW, Schnetz-Boutaud N, Haines JL, Pericak-Vance MA.
    Ann Hum Genet; 2009 May 01; 73(Pt 3):379-81. PubMed ID: 19472444
    [Abstract] [Full Text] [Related]

  • 18. A polymorphism in CALHM1 is associated with temporal lobe epilepsy.
    Lv RJ, He JS, Fu YH, Shao XQ, Wu LW, Lu Q, Jin LR, Liu H.
    Epilepsy Behav; 2011 Apr 01; 20(4):681-5. PubMed ID: 21439911
    [Abstract] [Full Text] [Related]

  • 19. The P86L common allele of CALHM1 does not influence risk for Alzheimer disease in Japanese cohorts.
    Inoue K, Tanaka N, Yamashita F, Sawano Y, Asada T, Goto YI.
    Am J Med Genet B Neuropsychiatr Genet; 2010 Mar 05; 153B(2):532-535. PubMed ID: 19655363
    [Abstract] [Full Text] [Related]

  • 20. Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress.
    Gallego-Sandín S, Alonso MT, García-Sancho J.
    Biochem J; 2011 Aug 01; 437(3):469-75. PubMed ID: 21574960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.